Today, we are delighted to present to you a rather special newsletter, marking the beginning of a series that is close to our hearts: the stories and experiences of people who use AtremoPlus. After a series of newsletters focused on…
For the third installment of our series dedicated to portraits and experiences of AtremoPlus users, we are pleased to present the moving story of Myriam, diagnosed with Parkinson’s at 52 years old. She shares with us her journey towards a more…
In this new issue of our newsletter, we invite you to discover the inspiring story of Mark Peever, a man who, thanks to his resilience, regained his zest for life after being diagnosed with Parkinson’s at the age of 62.…
Why choose a plant-based L-dopa Carbidopa? When people think of L-Dopa and Carbidopa, they often consider the synthetic version, which has long been used in managing Parkinson’s disease. However, did you know that nature offers a rich, diverse plant-based solution?…
In this new Portrait, we are pleased to give the word to Birgit Lange, who was diagnosed with Parkinson’s disease at the young age of 37. As the regional delegate of the dPV (German Parkinson’s Association), Birgit channels her fight…
In our latest newsletter, we discussed our commitment to understanding the mechanisms of action and measuring key parameters and biomarkers. This approach allows us to quantify the concrete impact on motor and cognitive performance, with observable effects shortly after initial intake. In…
In this new newsletter, we will delve deeper into our quest to make things measurable and thus quantify the improvements following the use of AtremoPlus. “Advances in medicine often result from the ability to accurately measure biological phenomena (…). Biomarkers…